AUF1, the regulator of tumor necrosis factor α messenger RNA decay, is targeted by autoantibodies of patients with systemic rheumatic diseases

Arthritis and Rheumatism

Volumn 58, Issue 2, 2008, Pages 511-520

  Skriner, Karl ^a,b   Hueber, Wolf Gang ^c   Süleymanoglu, Erhan ^b,e   Höfler, Elisabeth ^d   Krenn, Veit ^a   Smolen, Josef ^b   Steiner, Günter ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c STANFORD UNIVERSITY   (United States)

^d Hietzing Hospital   (Austria)

^e GAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EPITOPE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; RNA;

ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; ASSAY; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CYTOPLASM; FIBROBLAST; GEL RETARDATION ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MAJOR CLINICAL STUDY; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RNA BINDING; SERUM; SYNOVIUM; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 39749155758     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23306     Document Type: Article

References (33)

1. Von Muhlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995;24:323-58.
2. Van Venrooij W, Pruijn GJ. Ribonucleoprotein complexes as autoantigens. Curr Opin Immunol 1995;7:819-24.
3. Tan EM. Antinuclear antibodies: diagnostic markers of autoimmune diseases and probes for cell biology [review]. Adv Immunol 1989;4:93-151.
4. Hardin JA. The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthritis Rheum 1986;29:457-60.
5. Dreyfuss G, Matunis MJ, Pinol-Roma S, Burd CG. hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem 1993;62:289-321.
6. Tighe H, Carson DA. Rheumatoid factors. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB, editors. Textbook of rheumatology. 5th ed. Philadelphia: WB Saunders: 1997. p. 241-9.
7. Astaldi-Ricotti GC, Bestagno M, Cerini A, Negri R, Caporali R, Cobianchi F, et al. Antibodies to hnRNP core protein A1 in connective tissue diseases. J Cell Biochem 1989;40:1-5.
8. Montecucco C, Caporali R, Cobianchi F, Biamonti G. Identification of autoantibodies to the I protein of the heterogeneous nuclear ribonucleoprotein complex in patients with systemic sclerosis. Arthritis Rheum 1996;39:1669-76.
9. Hassfeld W, Steiner G, Studnicka-Benke A, Skriner K, Graninger W, Fischer I, et al. Autoimmune response to the spliceosome: an immunologic link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus. Arthritis Rheum 1995;38:777-85.
10. Pinol-Roma S, Dreyfuss G. Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm. Nature 1992;355:730-2.
11. Xu N, Chen CY, Shyu AB. Versatile role for hnRNP D isoforms in the differential regulation of cytoplasmic mRNA turnover. Mol Cell Biol 2001;21:6960-71.
12. Moraes KC, Quaresma AJ, Maehnss K, Kobarg J. Identification and characterization of proteins that selectively interact with isoforms of the mRNA binding protein AUF1 (hnRNP D). Biol Chem 2003;384:25-37.
13. Wagner BJ, DeMaria CT, Sun Y, Wilson GM, Brewer G. Structure and genomic organization of the human AUF1 gene: alternative pre-mRNA splicing generates four protein isoforms. Genomics 1998;48:195-202.
14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
15. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
16. Alarcon-Segovia D, Villareal M. Classification and diagnostic criteria for mixed connective tissue diseases. In: Kasukawa R, Sharp GC, editors. Mixed connective tissue diseases and antinuclear antibodies. Amsterdam: Elsevier; 1987. p. 33-40.
17. Steiner G, Hartmuth K, Skriner K, Maurer-Fogy I, Sinski A, Thalmann E, et al. Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. J Clin Invest 1992;90:1061-6.
18. Hel Z, Di Marco S, Radzioch D. Characterization of the RNA binding proteins forming complexes with a novel putative regulatory region in the 3′-UTR of TNF-α mRNA. Nucleic Acids Res 1998;26:2803-12.
19. Skriner K, Sommergruber WH, Tremmel V, Fischer I, Barta A, Smolen JS, et al. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex: differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease. J Clin Invest 1997;100:127-35.
20. Sheth U, Parker R. Decapping and decay of messenger RNA occur in cytoplasmic processing bodies. Science 2003;300:805-8.
21. DeMaria CT, Sun Y, Long L, Wagner BJ, Brewer G. Structural determinants in AUF1 required for high affinity binding to A + U-rich elements. J Biol Chem 1997;272:27635-43.
22. Loflin P, Chen CY, Shyu AB. Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. Genes Dev 1999;13:1884-97.
23. Fritsch R, Eselbock D, Skriner K, Jahn-Schmid B, Scheinecker C, Bohle B, et al. Characterization of autoreactive T cells to the autoantigens heterogeneous nuclear ribonucleoprotein A2 (RA33) and filaggrin in patients with rheumatoid arthritis. J Immunol 2002;169:1068-76.
24. Hayer S, Tohidast-Akrad M, Haralambous S, Jahn-Schmid B, Skriner K, Trembleau S, et al. Aberrant expression of the autoantigen heterogeneous nuclear ribonucleoprotein-A2 (RA33) and spontaneous formation of rheumatoid arthritis-associated anti-RA33 autoantibodies in TNF-α transgenic mice. J Immunol 2005;175:8327-36.
25. Lal A, Mazan-Mamczarz K, Kawai T, Yang X, Martindale JL, Gorospe M. Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J 2004;23:3092-102.
26. Eystathioy T, Chan EK, Tenenbaum SA, Keene JD, Griffith K, Fritzler MJ. A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles. Mol Biol Cell 2002;13:1338-51.
27. Cougot N, Babajko S, Seraphin B. Cytoplasmic foci are sites of mRNA decay in human cells. J Cell Biol 2004;165:31-40.
28. Van Hoof A, Parker R. The exosome: a proteasome for RNA? Cell 1999;99:347-50.
29. Sully G, Dean JL, Wait R, Rawlinson L, Santalucia T, Saklatvala J, et al. Structural and functional dissection of a conserved destabilizing element of cyclo-oxygenase-2 mRNA: evidence against the involvement of AUF-1 (AU-rich element/poly[U]-binding/degradation factor-1), AUF-2, tristetraprolin, HuR (Hu antigen R) or FBP1 (far-upstream-sequence-element-binding protein 1). Biochem J 2004;377(Pt 3):629-39.
30. Ge Q, Frank MB, O'Brien C, Targoff. Cloning of a complementary DNA coding for the 100-kD antigenic protein of the PM-Scl autoantigen. J Clin Invest 1992;90:559-70.
31. Alderuccio F, Chan EK, Tan EM. Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex. J Exp Med 1991;173:941-52.
32. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 1999;10:387-98.
33. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992;10:411-52.